Prof Jeanne Tie
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
338 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Circulating tumour DNA in colorectal cancer: current and emerging clinical applications
DOI: 10.20935/acadonco82792026
Journal article
How Survivors of Colorectal Cancer Experience ctDNA Testing and Fear of Recurrence
DOI: 10.1002/pon.704642026
Journal article
Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE Trial
DOI: 10.1001/jamaoncol.2025.61962026
Journal article
Long-term survival outcomes after biomarker-guided thromboprophylaxis in cancer: extended follow-up of the TARGET-TP randomised trial.
DOI: 10.1093/jnci/djag0652026
Journal article
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer
DOI: 10.1016/S1470-2045(25)00714-42026
Journal article
Impact of RAS/BRAFV600E Mutations on the Tumor Immune Microenvironment in Mismatch Repair–Deficient/Microsatellite Instability Colorectal Cancers
DOI: 10.1158/1078-0432.CCR-25-21602026
Research grants (ARC, NHMRC, MRFF)
Advancing Precision Medicine for Colorectal Cancer Through Liquid Biopsy
RECENT SCHOLARLY WORKS
2026
Journal article
A phase 1b/2, multicenter, open-label study to evaluate the efficacy and safety of GSK5764227 (GSK’227), alone and in combination in patients with previously treated advanced unresectable or metastatic gastrointestinal solid tumors.
DOI: 10.1200/jco.2026.44.2_suppl.tps2642026
Journal article
BREAKWATER phase 3: Post hoc subgroup analyses by age in patients (pts) with BRAF V600E-mutant metastatic colorectal cancer (mCRC).
DOI: 10.1200/jco.2026.44.2_suppl.1222026
Journal article
Late-line Systemic Therapy in Metastatic Colorectal Cancer: A Narrative Review and Australian Expert Perspective
DOI: 10.1016/j.clcc.2026.04.0012026
Journal article
Pre-emptive DPYD genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients
DOI: 10.1177/10781552261445956